Mantle Cell Lymphoma - Window 2 clinical trial

[writepa]

Just wonder if anyone participates in Window 2 clinical trial of MD Anderson where patients receive Ibrutinib in the first 4 months, combine with Rituximab and add Venetoclax in month 5. Chemo will be followed if in the medium and high risk. Then another 2-3 years in maintenance with Ibrutiniv, Venetoclax and Rituximab.

Any idea or advice, please whether to join this trial?

[avzuclav]

I don't think you'll find much information here since it is a CLL community. I had a relative in the MCL Window 1 MDA clinical trial which was similar but did not include venetoclax. Feel free to send me a chat message for details.

I think this is one of the best trials for MCL.